Cite

HARVARD Citation

    Tun, G. et al. (2022). The effect of infliximab dose escalation in inflammatory bowel disease patients with antibodies to infliximab. European journal of gastroenterology & hepatology. 34 (3), p. . [Online]. 
  
Back to record